Physician profile
John Leahy
NPI 1396008405
$6,730.92
in general payments reported to CMS, 2019-2025
32 companies · $18.55 in 2025
The $18.55 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $376 · 2020: $139 · 2021: $1,584 · 2022: $1,047 · 2023: $2,941 · 2024: $625 · 2025: $18.55.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,944 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,640.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,944.44 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,640.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $2,291.63 | 2023-2024 | Myfembree |
| Acessa Health INC. | $1,035.96 | 2021 | |
| Myovant Sciences INC. | $716.95 | 2021-2022 | |
| Abbvie INC. | $356.53 | 2019-2024 | |
| Hologic Sales and Service, LLC | $230.21 | 2019-2025 | Aptima, Thinprep 2000 Processor, Acessa Provu System |
| Aspira Women'S Health INC | $223.34 | 2019-2021 | |
| Gynesonics, INC. | $173.78 | 2023-2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Organon LLC | $163.60 | 2021-2024 | Nexplanon |
| Exeltis, USA INC. | $156.90 | 2019-2024 | Slynd |
| Meditrina | $145.00 | 2023-2024 | |
| Coopersurgical, INC. | $138.83 | 2019-2024 | Paragard T 380a, Paragard T 380a |
| Mayne Pharma Commercial LLC | $134.93 | 2022-2023 | |
| Therapeuticsmd, INC. | $131.27 | 2021-2022 | |
| Astellas Pharma US INC | $129.60 | 2023-2024 | Veozah |
| Daiichi Sankyo INC. | $109.44 | 2020-2024 | Injectafer |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lupin INC. | $91.68 | 2019-2020 | |
| Pfizer INC. | $63.60 | 2023-2024 | |
| Agile Therapeutics, INC. | $55.17 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $53.20 | 2019-2023 | |
| Medtronic, INC. | $41.02 | 2022 | |
| Merck Sharp & Dohme LLC | $40.10 | 2023-2024 | Gardasil 9, Gardasil |
| Exact Sciences Corporation | $37.94 | 2023-2024 | Cologuard Collection Kit |
| Evofem Biosciences, INC. | $30.54 | 2022 | |
| Mylan Pharmaceuticals INC. | $30.39 | 2019-2022 | |
| Dexcom, INC. | $23.85 | 2023 | Dexcom G6 Transmitter |
| Pacira Pharmaceuticals Incorporated | $22.30 | 2024 | Exparel |
| Medicem INC. | $20.50 | 2023 | |
| Mycovia Pharmaceuticals, INC. | $19.98 | 2023 | Vivjoa |
| Sage Therapeutics, LLC | $17.26 | 2022 | |
| Smith+Nephew, INC. | $16.63 | 2023 | Stravix |
| Shield Therapeutics INC | $15.41 | 2023 | Accrufer |
| Amag Pharmaceuticals, INC. | $13.38 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Leahy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.